Medicare Enrolled

Dr. Neel Amin, M.D.

Interventional Pain Medicine Physician · Fort Lauderdale, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1345 NE 4TH AVE, Fort Lauderdale, FL 33304
9544581199
In practice since 2007 (19 years)
NPI: 1801919410 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amin

Dr. Neel Amin is an interventional pain medicine physician in Fort Lauderdale, FL, with 19 years in practice. Based on federal Medicare data, Dr. Amin performed 36,441 Medicare services across 1,586 unique beneficiaries.

Between the years covered by Open Payments, Dr. Amin received a total of $15,400 from 51 pharmaceutical and/or device companies across 842 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 4% volume in FL$ $15,400 industry payments

Medicare Practice Summary

Medicare Utilization ↗
36,441
Medicare services
Top 4% in FL for interventional pain medicine physician
1,586
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,918 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging, lower concentration22,660$0$5
Dexamethasone injection (steroid)9,045$0$10
Joint lubricant injection (GenVisc)1,025$5$20
Office visit, established patient (30-39 min)776$98$290
Injection, ketorolac tromethamine, per 15 mg555$0$25
Drug screening test478$60$200
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms471$192$899
Injection of trigger points, 3 or more muscles176$46$175
Joint injection, major joint140$54$170
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level129$289$625
Fluoroscopic guidance for needle placement115$92$280
Injection of anesthetic agent and/or steroid into other nerve or branch88$71$205
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance82$196$435
Injection of substance into middle or upper spine canal using imaging guidance70$199$685
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint66$524$1,000
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint65$288$750
Injection of substance into lower spine canal using imaging guidance64$204$675
Ultrasonic guidance for needle placement62$47$300
New patient office visit (45-59 min)45$125$450
Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve)43$124$335
Injection of upper or middle spine facet joint using imaging guidance, single level39$233$505
Injection of upper or middle spine facet joint using imaging guidance, second level39$119$255
Injection of lower or sacral spine facet joint using imaging guidance, single level38$215$460
Injection of lower or sacral spine facet joint using imaging guidance, second level37$111$240
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint31$529$1,100
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint31$311$750
Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block25$27$95
Insertion of spinal neurostimulator electrode array through skin24$1,365$4,688
Injection of anesthetic agent and/or steroid into rib nerve22$83$270
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,400
Total received (2018-2024)
Avg $2,200/year across 7 years
Top 16% in FL for interventional pain medicine physician
51
Companies
842
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,400 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,420
2023
$2,118
2022
$1,880
2021
$1,917
2020
$2,510
2019
$2,735
2018
$1,821

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,203
Collegium Pharmaceutical, Inc.
$1,594
Nevro Corp.
$1,313
Boston Scientific Corporation
$1,076
Medtronic, Inc.
$971
Nalu Medical, Inc.
$794
Horizon Therapeutics plc
$512
Zyla Life Sciences
$500
Egalet US Inc
$430
Allergan, Inc.
$427
Scilex Pharmaceuticals Inc.
$372
Medtronic USA, Inc.
$338
BioDelivery Sciences International, Inc.
$327
Allergan Inc.
$326
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$285
ABBVIE INC.
$284
AbbVie Inc.
$265
RedHill Biopharma Inc.
$241
SCILEX PHARMACEUTICALS INC.
$227
DePuy Synthes Sales Inc.
$212
Zyla Life Sciences, Inc.
$197
PFIZER INC.
$186
Daiichi Sankyo Inc.
$168
SPR Therapeutics, Inc
$117
Stryker Corporation
$116
Valinor Pharma, LLC
$115
Pernix Therapeutics Holdings, Inc.
$92
Biohaven Pharmaceutical Holding Company Ltd.
$84
Purdue Pharma L.P.
$64
Siemens Medical Solutions USA, Inc.
$49
Nuvectra Corporation
$46
Vertos Medical, Inc.
$46
AstraZeneca Pharmaceuticals LP
$44
Spinal Simplicity, LLC
$36
Stimwave Technologies Incorporated
$33
Shionogi Inc
$32
Kaleo, Inc.
$28
Sentynl Therapeutics, Inc.
$27
Merz North America, Inc.
$24
TerSera Therapeutics LLC
$21
Virtus Pharmaceuticals LLC
$21
Avanos Medical
$20
BOSTON SCIENTIFIC CORPORATION
$19
Biohaven Pharmaceuticals, Inc.
$19
Vertical Pharmaceuticals, LLC
$19
Horizon Pharma plc
$16
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
Insulet Corporation
$14
Bioventus LLC
$13
Vertiflex, Inc.
$12
Hikma Pharmaceuticals USA
$12
Top 3 companies account for 39.7% of total payments
Associated products mentioned in payments ›
ARYMO ER · Accurian · Algovita · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Cios Select · DUEXIS · Durolane · ETERNA · EVZIO · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENVISC 850 SODIUM HYALURONATE · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON EXPRESS II KYPHOPAK TRAY · LEVORPHANOL TARTRATE · LYRICA · Levorphanol · Levorphanol Tartrate · METHYLPHENIDATE 72 · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NURTEC ODT · Nalu Neurostimulation System · ORTHOVISC · Omnia · Omnipod · PENNSAID · PRIALT · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · RAYOS · RELISTOR · RELISTOR ORAL · SCS IPGs · SCS leads · SERRATO · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SYMPROIC · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Superion ISS · Symproic · TREXIMET · UBRELVY · VIMOVO · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · kloxxado · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $42 per 100 Medicare services performed
Looking for a interventional pain medicine physician in Fort Lauderdale?
Compare interventional pain medicine physicians in the Fort Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse interventional pain medicine physicians nearby

Geographic Context

Interventional Pain Medicine Physicians within 10 mi
29
Per 100K population
1.5
County median income
$74,534
Nearest hospital
BROWARD HEALTH MEDICAL CENTER
2.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Amin is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and high industry engagement (low-engagement, top 16%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Amin experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Amin performed 22,660 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amin receive payments from pharmaceutical companies?
Yes. Dr. Amin received a total of $15,400 from 51 companies across 842 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amin's costs compare to other interventional pain medicine physicians in Fort Lauderdale?
Dr. Amin's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →